TerrAscend (TSNDF) Total Liabilities (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Total Liabilities of $458.2 million for Q1 2026, up 5.17% year-over-year from $435.6 million in Q1 2025, and little changed quarter-over-quarter from $458.4 million in Q4 2025.
TerrAscend (TSNDF) Total Liabilities (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Total Liabilities for 6 consecutive years, with $458.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities rose 5.17% year-over-year to $458.2 million; the TTM figure through Mar 2026 stood at $458.2 million (up 5.17% YoY), while the FY2025 annual figure was $458.4 million, up 6.49% from the prior year.
- Total Liabilities held at $458.2 million in Q1 2026 per TSNDF's latest filing, from $458.4 million in the prior quarter.
- Across five years, Total Liabilities topped out at $511.2 million in Q1 2022 and bottomed at $380.4 million in Q4 2022.
- Historically, Total Liabilities has averaged $441.7 million across 5 years, with a median of $446.7 million in 2022.
- On a YoY basis, Total Liabilities climbed as much as 11.92% in 2023 and fell as far as 21.3% in 2023.
- TerrAscend's Total Liabilities stood at $380.4 million in 2022, then climbed by 11.92% to $425.8 million in 2023, then rose by 1.09% to $430.4 million in 2024, then grew by 6.49% to $458.4 million in 2025, then retreated by 0.04% to $458.2 million in 2026.
- Business Quant data shows TSNDF's Total Liabilities at $458.2 million in Q1 2026, $458.4 million in Q4 2025, and $459.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn | 469.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 469.66 Mn |
| Mar 31, 2026 | 458.16 Mn |
| Dec 31, 2025 | 458.36 Mn |
| Sep 30, 2025 | 459.78 Mn |
| Jun 30, 2025 | 453.62 Mn |
| Mar 31, 2025 | 435.63 Mn |
| Dec 31, 2024 | 430.42 Mn |
| Sep 30, 2024 | 449.81 Mn |
| Jun 30, 2024 | 434.10 Mn |
| Mar 31, 2024 | 423.43 Mn |
| Dec 31, 2023 | 425.78 Mn |
| Sep 30, 2023 | 449.88 Mn |
| Jun 30, 2023 | 426.15 Mn |
| Mar 31, 2023 | 402.28 Mn |
| Dec 31, 2022 | 380.42 Mn |
| Sep 30, 2022 | 446.67 Mn |
| Jun 30, 2022 | 463.65 Mn |
| Mar 31, 2022 | 511.16 Mn |
| Dec 31, 2021 | 352.98 Mn |